Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q3 2022 Program Management Update

31 Oct 2022 07:00

RNS Number : 5708E
R&Q Insurance Holdings Ltd
31 October 2022
 

 

R&Q Insurance Holdings Ltd

 

Q3 2022 Program Management Update

 

GWP grows by over 80% to $1.3 billion for the nine months ending 30 September 2022

 

31 October 2022

 

R&Q Insurance Holdings Ltd, (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business for the nine months ending 30 September 2022.

 

Highlights

 

· Gross Written Premium ('GWP') of $1.3 billion (9m 2021: $714 million), an 83% increase

 

· Program Fee Income of $60 million (9m 2021: $30 million), a 100% increase1

 

William Spiegel, Executive Group Chairman, commented:

 

"Our Program Management business exhibited strong year-over-year growth as we continued to expand the depth and breadth of our MGA partnerships through the first nine months of 2022. Our team continues to find new and unique ways to meet the needs of our MGAs and reinsurance partners, as demonstrated in our recently announced multi-year transaction with Inperio. Additionally, I am pleased to report that our growth is broad-based with all three of our platforms (US Admitted, US Non-Admitted, and Europe) growing GWP and Fee Income. Looking forward, our pipeline of new MGA opportunities remains strong."

 

Notes:

1. Program Fee Income is on a written basis and excludes our share of earnings from minority stakes in MGAs.

 

Ends

 

Enquiries to:

 

R&Q Insurance Holdings Ltd

William Spiegel

Tel: 0207 780 5850

Tom Solomon

Tel: 0207 780 5850

Alan Quilter Tel: 020 7780 5960

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Andrew Tusa

Anusuya Nayar Gupta

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKKBNDBDDFKN
Date   Source Headline
8th Oct 20197:39 amRNSCompletion of acquisition
2nd Oct 20192:12 pmRNSResult of General Meeting
2nd Oct 20197:00 amRNSR&Q appoints Chief Restructuring Officer
25th Sep 20197:00 amRNSA.M. Best rating
9th Sep 20199:59 amRNSNotice of General Meeting and Return of Capital
6th Sep 20197:01 amRNSRetirement of Director
6th Sep 20197:00 amRNSInterim Results
22nd Aug 20197:00 amRNSLegacy agreement
21st Aug 20197:00 amRNSProgram underwriting partnerships
8th Aug 20197:00 amRNSR&Q provides legacy reinsurance for captive
12th Jul 20197:00 amRNSDirectors' Shareholding/Total Voting Rights
3rd Jul 20197:00 amRNSLoss Portfolio Transfer
1st Jul 20197:00 amRNSAcquisition
1st Jul 20197:00 amRNSTransaction with Phoenix Asset Management Partners
19th Jun 20194:49 pmRNSAnnual Report & Accounts
19th Jun 20197:00 amRNSDirectorate Change
13th Jun 20197:00 amRNSResult of Annual General Meeting
21st May 20197:50 amRNSDirectors' Shareholding/Total Voting Rights
20th May 20197:00 amRNSNotice of AGM and Proposed Return of Capital
8th May 20195:30 pmRNSEarthport
7th May 201910:58 amRNSDirectors' Shareholding/Total Voting Rights
7th May 20197:00 amRNSBoard Appointment
3rd May 20197:00 amRNSCompletion of Acquisition
30th Apr 20197:00 amRNSPDMR Shareholding/Total Voting Rights
29th Apr 20197:00 amRNSFinal results
23rd Apr 201912:24 pmRNSRegulatory approval for acquisition
1st Apr 20197:00 amRNSAcquisition
25th Mar 20197:00 amRNSListing of Senior Unsecured Floating Rate Notes
21st Mar 20197:00 amRNSProgram underwriting partnership
20th Mar 20198:00 amRNSAccredited A.M. Best Group rating increase
15th Mar 201911:05 amRNSNotification of major interest in shares
6th Mar 20192:30 pmRNSPDMR Share Dealings
6th Mar 20192:30 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
6th Mar 20192:30 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
5th Mar 201912:05 pmRNSResult of General Meeting and Open Offer
4th Mar 20197:00 amRNSAcquisition
25th Feb 20197:00 amRNSProgram underwriting partnership
14th Feb 20197:00 amRNSAM Best affirms ratings
8th Feb 20199:00 amRNSPosting of Circular
7th Feb 20197:00 amRNSPlacing and open offer
10th Jan 20197:00 amRNSR&Q completes on two further transactions
8th Jan 201912:13 pmRNSCompletion of acquisition
7th Jan 20197:00 amRNSProgram underwriting partnership
4th Jan 201910:12 amRNSDirectors' Shareholding
3rd Jan 20197:00 amRNSProgram underwriting partnership
11th Dec 201811:53 amRNSUpdate on Acquisition
28th Nov 20187:00 amRNSR&Q completes two transactions
30th Oct 201812:15 pmRNSResult of General Meeting
30th Oct 20188:00 amRNSFacultative reinsurance certificate to US carrier
8th Oct 20187:00 amRNSPDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.